| Insurance Industry | Financials Sector | Dr. Thomas Richard Young M.D. CEO | SET Exchange | AU000000MEB8 ISIN |
| Australia Country | - Employees | - Last Dividend | 23 Oct 2023 Last Split | - IPO Date |
Medibio Limited is a pioneering health technology company operating out of Mount Lawley, Australia, with its efforts focused on the international stage, particularly in Australia and the United States. The company's mission revolves around the advancement of diagnostic and screening techniques for mental health conditions. Initially established under the name BioProspect Limited in 1987, it underwent a significant transformation, rebranding to Medibio Limited in November 2014. This rebranding marked the company's strategic pivot towards mental health technologies, reinforcing its commitment to addressing the challenges within this critical domain of healthcare.
Medibio Limited has developed a suite of innovative products and services designed to support mental well-being in various contexts, each tailored to meet the diverse needs of its users: